Alector, Inc. Financing Cash Flow
Alector, Inc. (ALEC) reported Financing Cash Flow of $75.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- Alector, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $50.00K, a 59.02% decline year-over-year.
- Alector, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $25.00K.
- Alector, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $5.39M, a 44.91% decline year-over-year.
- Alector, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $14.70M.
- Alector, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $20.21M, a 75.21% decline from fiscal 2024.
- Alector, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $81.54M, a 3097.65% increase from fiscal 2023.
- Alector, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $2.55M, a 43.51% decline from fiscal 2022.
- Alector, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $4.51M, a 85.10% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $75.00K 10-Q · filed 2026-08-06 | $5.47M derived: sum of 3 quarters · filed 2026-08-06 | $20.17M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $25.00K 10-Q · filed 2026-05-07 | $5.42M derived: sum of 2 quarters · filed 2026-05-07 | $20.12M derived: sum of 3 quarters · filed 2026-05-07 | $20.24M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $5.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $20.09M derived: sum of 2 quarters · filed 2026-02-25 | $20.21M derived: sum of 3 quarters · filed 2026-08-06 | $20.21M 10-K · filed 2026-02-25 |
| 2025-09-30 | $14.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $14.82M derived: sum of 2 quarters · filed 2026-08-06 | $14.82M 10-Q · filed 2025-11-06 | $24.61M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $122.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $122.00K 10-Q · filed 2026-08-06 | $9.91M derived: sum of 3 quarters · filed 2026-08-06 | $9.91M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | $9.79M derived: sum of 2 quarters · filed 2026-05-07 | $9.79M derived: sum of 3 quarters · filed 2026-05-07 | $10.43M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $9.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $9.79M derived: sum of 2 quarters · filed 2026-02-25 | $10.43M derived: sum of 3 quarters · filed 2026-02-25 | $81.54M 10-K · filed 2026-02-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $644.00K derived: sum of 2 quarters · filed 2025-11-06 | $71.75M 10-Q · filed 2025-11-06 | $72.34M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $644.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $71.75M 10-Q · filed 2025-08-07 | $72.34M derived: sum of 3 quarters · filed 2025-08-07 | $72.34M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $71.11M 10-Q · filed 2025-05-08 | $71.70M derived: sum of 2 quarters · filed 2025-05-08 | $71.70M derived: sum of 3 quarters · filed 2025-05-08 | $72.58M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $590.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $590.00K derived: sum of 2 quarters · filed 2025-02-26 | $1.47M derived: sum of 3 quarters · filed 2025-02-26 | $2.55M 10-K · filed 2025-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $881.00K derived: sum of 2 quarters · filed 2024-11-06 | $1.96M 10-Q · filed 2024-11-06 | $2.60M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $881.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.96M 10-Q · filed 2024-08-07 | $2.60M derived: sum of 3 quarters · filed 2025-02-26 | $3.08M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $1.08M 10-Q · filed 2024-05-08 | $1.72M derived: sum of 2 quarters · filed 2025-02-26 | $2.20M derived: sum of 3 quarters · filed 2025-02-26 | $3.11M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $636.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $1.13M derived: sum of 2 quarters · filed 2025-02-26 | $2.03M derived: sum of 3 quarters · filed 2025-02-26 | $4.51M 10-K · filed 2025-02-26 |
| 2022-09-30 | $489.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.40M derived: sum of 2 quarters · filed 2023-11-07 | $3.88M 10-Q · filed 2023-11-07 | $12.52M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $906.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $3.39M 10-Q · filed 2023-08-03 | $12.03M derived: sum of 3 quarters · filed 2024-02-27 | $26.85M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $2.48M 10-Q · filed 2023-05-04 | $11.12M derived: sum of 2 quarters · filed 2024-02-27 | $25.94M derived: sum of 3 quarters · filed 2024-02-27 | $28.90M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $8.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $23.46M derived: sum of 2 quarters · filed 2024-02-27 | $26.42M derived: sum of 3 quarters · filed 2024-02-27 | $30.30M 10-K · filed 2024-02-27 |
| 2021-09-30 | $14.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $17.78M derived: sum of 2 quarters · filed 2022-11-08 | $21.66M 10-Q · filed 2022-11-08 | $22.75M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $2.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $6.84M 10-Q · filed 2022-08-04 | $7.93M derived: sum of 3 quarters · filed 2023-02-28 | $8.22M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $3.87M 10-Q · filed 2022-05-05 | $4.97M derived: sum of 2 quarters · filed 2023-02-28 | $5.26M derived: sum of 3 quarters · filed 2023-02-28 | $7.53M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.38M derived: sum of 2 quarters · filed 2023-02-28 | $3.65M derived: sum of 3 quarters · filed 2023-02-28 | $232.11M 10-K · filed 2023-02-28 |
| 2020-09-30 | $286.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.56M derived: sum of 2 quarters · filed 2021-11-04 | $231.02M 10-Q · filed 2021-11-04 | $232.45M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $230.73M 10-Q · filed 2021-08-03 | $232.17M derived: sum of 3 quarters · filed 2022-02-24 | $232.89M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $228.46M 10-Q · filed 2021-05-05 | $229.90M derived: sum of 2 quarters · filed 2022-02-24 | $230.62M derived: sum of 3 quarters · filed 2022-02-24 | $230.50M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.16M derived: sum of 2 quarters · filed 2022-02-24 | $2.04M derived: sum of 3 quarters · filed 2022-02-24 | $172.35M 10-K · filed 2022-02-24 |
| 2019-09-30 | $720.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $604.00K derived: sum of 2 quarters · filed 2020-11-10 | $170.92M 10-Q · filed 2020-11-10 | $169.64M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $170.20M 10-Q · filed 2020-08-11 | $168.92M derived: sum of 3 quarters · filed 2021-02-25 | $231.25M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $170.31M 10-Q · filed 2020-05-13 | $169.03M derived: sum of 2 quarters · filed 2021-02-25 | $231.37M derived: sum of 3 quarters · filed 2021-02-25 | $301.52M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $61.05M derived: sum of 2 quarters · filed 2021-02-25 | $131.21M derived: sum of 3 quarters · filed 2021-02-25 | $131.15M 10-K · filed 2021-02-25 |
| 2018-09-30 | $62.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $132.49M derived: sum of 2 quarters · filed 2019-11-12 | $132.43M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $70.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $70.09M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | -$62.00K 10-Q · filed 2019-05-13 | |||
| 2017-12-31 | -$15.00K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |